WO2001042205A3 - Treatment of inflammatory bowel disease with vitamin d compounds - Google Patents
Treatment of inflammatory bowel disease with vitamin d compounds Download PDFInfo
- Publication number
- WO2001042205A3 WO2001042205A3 PCT/US2000/042393 US0042393W WO0142205A3 WO 2001042205 A3 WO2001042205 A3 WO 2001042205A3 US 0042393 W US0042393 W US 0042393W WO 0142205 A3 WO0142205 A3 WO 0142205A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- inflammatory bowel
- bowel disease
- compounds
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001543506A JP2003516386A (en) | 1999-12-02 | 2000-11-30 | Treatment of inflammatory bowel disease with vitamin D compounds |
AU45100/01A AU4510001A (en) | 1999-12-02 | 2000-11-30 | Treatment of inflammatory bowel disease with vitamin d compounds |
EP00992552A EP1233942A2 (en) | 1999-12-02 | 2000-11-30 | Treatment of inflammatory bowel disease with vitamin d compounds |
CA002390859A CA2390859A1 (en) | 1999-12-02 | 2000-11-30 | Treatment of inflammatory bowel disease with vitamin d compounds |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16850199P | 1999-12-02 | 1999-12-02 | |
US60/168,501 | 1999-12-02 | ||
US19782700P | 2000-04-14 | 2000-04-14 | |
US60/197,827 | 2000-04-14 | ||
US20863200P | 2000-06-01 | 2000-06-01 | |
US60/208,632 | 2000-06-01 | ||
US23190600P | 2000-09-11 | 2000-09-11 | |
US60/231,906 | 2000-09-11 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/969,394 Continuation US20050070513A1 (en) | 1999-12-02 | 2004-10-20 | Treatment of inflammatory bowel disease with vitamin D compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001042205A2 WO2001042205A2 (en) | 2001-06-14 |
WO2001042205A3 true WO2001042205A3 (en) | 2002-03-21 |
Family
ID=27496796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/042393 WO2001042205A2 (en) | 1999-12-02 | 2000-11-30 | Treatment of inflammatory bowel disease with vitamin d compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1233942A2 (en) |
JP (1) | JP2003516386A (en) |
AU (1) | AU4510001A (en) |
CA (1) | CA2390859A1 (en) |
WO (1) | WO2001042205A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
US6989377B2 (en) * | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
AU2012326485B2 (en) * | 2011-10-21 | 2016-12-08 | Wisconson Alumni Research Foundation | 2-methylene-vitamin D analogs and their uses |
JP6397695B2 (en) * | 2014-08-25 | 2018-09-26 | 学校法人自治医科大学 | Anti-pylori agent |
EP3331533B1 (en) * | 2015-08-05 | 2021-09-01 | Wisconsin Alumni Research Foundation | Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds |
WO2021161312A1 (en) * | 2020-02-11 | 2021-08-19 | The E. Wolfson Medical Center | A method effective for treating ulcerative colitis |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05294834A (en) * | 1990-02-09 | 1993-11-09 | Teijin Ltd | Treating agent containing activated vitamin d |
DE4405545A1 (en) * | 1994-02-22 | 1995-08-31 | Dietl Hans | Oral vitamin compsn. with improved resorption |
WO1996030326A1 (en) * | 1995-03-30 | 1996-10-03 | The Trustees Of The University Of Pennsylvania | Differentiating agents for the treatment of inflammatory intestinal diseases |
US5583125A (en) * | 1992-10-06 | 1996-12-10 | Schering Aktiengesellschaft | 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents |
US5663157A (en) * | 1992-06-30 | 1997-09-02 | Schering Aktiengesellschaft | 22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents |
WO1998051678A1 (en) * | 1997-05-16 | 1998-11-19 | Women & Infants Hospital | CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
WO1998051664A1 (en) * | 1997-05-16 | 1998-11-19 | Women & Infants Hospital | 3-epi vitamin d2 compounds and uses thereof |
WO1999003828A1 (en) * | 1997-07-17 | 1999-01-28 | F.Hoffmann-La Roche Ag | Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
-
2000
- 2000-11-30 EP EP00992552A patent/EP1233942A2/en not_active Withdrawn
- 2000-11-30 WO PCT/US2000/042393 patent/WO2001042205A2/en not_active Application Discontinuation
- 2000-11-30 CA CA002390859A patent/CA2390859A1/en not_active Abandoned
- 2000-11-30 AU AU45100/01A patent/AU4510001A/en not_active Abandoned
- 2000-11-30 JP JP2001543506A patent/JP2003516386A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05294834A (en) * | 1990-02-09 | 1993-11-09 | Teijin Ltd | Treating agent containing activated vitamin d |
US5663157A (en) * | 1992-06-30 | 1997-09-02 | Schering Aktiengesellschaft | 22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents |
US5583125A (en) * | 1992-10-06 | 1996-12-10 | Schering Aktiengesellschaft | 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents |
DE4405545A1 (en) * | 1994-02-22 | 1995-08-31 | Dietl Hans | Oral vitamin compsn. with improved resorption |
WO1996030326A1 (en) * | 1995-03-30 | 1996-10-03 | The Trustees Of The University Of Pennsylvania | Differentiating agents for the treatment of inflammatory intestinal diseases |
WO1998051678A1 (en) * | 1997-05-16 | 1998-11-19 | Women & Infants Hospital | CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
WO1998051664A1 (en) * | 1997-05-16 | 1998-11-19 | Women & Infants Hospital | 3-epi vitamin d2 compounds and uses thereof |
WO1999003828A1 (en) * | 1997-07-17 | 1999-01-28 | F.Hoffmann-La Roche Ag | Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
Non-Patent Citations (3)
Title |
---|
DATABASE CHEMABS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002167821 * |
PATENT ABSTRACTS OF JAPAN vol. 018, no. 093 16 February 1994 (1994-02-16) * |
See also references of EP1233942A2 * |
Also Published As
Publication number | Publication date |
---|---|
EP1233942A2 (en) | 2002-08-28 |
CA2390859A1 (en) | 2001-06-14 |
AU4510001A (en) | 2001-06-18 |
WO2001042205A2 (en) | 2001-06-14 |
JP2003516386A (en) | 2003-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG19642A (en) | A process for the preparation of oral composition for the treatment of inflammatory bowel diseases | |
NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
WO1999046279A3 (en) | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE | |
WO2002056912A3 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
CA2189658A1 (en) | Controlled-Release Dosage Forms of Azithromycin | |
WO2003072040A3 (en) | Administration of agents for the treatment of inflammation | |
CA2186673A1 (en) | The use of fatty acids in the treatment of huntington's chorea | |
CA2289717A1 (en) | Novel therapy for constipation | |
AU6915396A (en) | Multiple sclerosis treatment | |
ATE448788T1 (en) | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH 2-METHYLENE-19-NOR-VITAMIN D COMPOUNDS | |
WO2001042205A3 (en) | Treatment of inflammatory bowel disease with vitamin d compounds | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
WO2000066098A3 (en) | Vitamin d derivatives for the treatment of systemic lupus erythematosus | |
PT1237562E (en) | PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
CA2234936A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine | |
WO2002076400A3 (en) | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | |
AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
WO2000010590A3 (en) | Cancer treatment | |
WO1998025594A3 (en) | Lamotrigine in the treatment and prophylaxis of migraine | |
RU99104916A (en) | METHOD FOR TREATING PATIENTS WITH Nonspecific ulcerative colitis | |
WO2000033823A3 (en) | Methods of using temozolomide in the treatment of cancers | |
RU2000103385A (en) | METHOD FOR TREATING ACUTE PANCREOTITIS | |
WO2002076405A3 (en) | Compositions and methods of treatment of ulcerating diseases, burns, and related conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 543506 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2390859 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 45100/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000992552 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10148620 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000992552 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000992552 Country of ref document: EP |